nejm.org
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate va...